Table 1

Survey sample sizes, sex and age, response rates and measurement methods
Cambodia Malaysia Mongolia
Date of data collection Feb – Apr 2010 Sep 2005 – Feb 2006 Oct-Dec 2009
Response rate
 Questionnaire 96.3% 84.6% 95%
 Physical measurements 94.2% 84.6% 95%
Biochemical measurements 92.7% 84.6% 95%1
Sample size aged (25–64) 5,433 2,572 4,539
Sample size aged (40–64 years) 3244 1631 2234
Sample size aged 40–64 years with data on DM & HT & included in the current study for CVD risk assessment 3090 1618 8451
 Male: % 35.0 42.3 40.5
 Unweighted (N) (1137) (690) (905)
 Weighted (%) 47.4 51.3 50.3
 Age in years: mean (SD)
 Unweighted 49.7 (0.15) 50.3 (0.17) 49.2 (0.14)
 Weighted 50.7 (0.12) 49.2 (0.71) 48.9(0.16)
Measurement of Blood pressure (measured 3 times in sitting position) NISSEI Digital Blood Pressure Monitor (Model DS-500) Stethoscope & mercury-stand sphygmomanometer Omron Model 5 Automatic Blood Pressure Monitor
Measurement of fasting Blood/plasma sugar and cholesterol Whole capillary blood taken from fingertips; dry chemical reagent strips & Accutrend GCT instruments 5 ml venous blood; plasma glucose: enzymatic assay kit (GlucoseFlex® reagent cartridge); total cholesterol: enzymatic colorimetric tests Same as in Cambodia

1 Biochemical measurements were carried out only on one-third of total sampled population in the age group 25–64 years old in Mongolia.

Otgontuya et al.

Otgontuya et al. BMC Public Health 2013 13:539   doi:10.1186/1471-2458-13-539

Open Data